Overview

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
This study investigates whether sirolimus could decrease the rate of hepatoma recurrence after liver transplantation in high risk hepatoma patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Alberta
Treatments:
Everolimus
Sirolimus